azomycin has been researched along with allopurinol in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (44.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallerano, RH; Marr, JJ; Sosa, RR | 1 |
| Argenbright, LS; Kedderis, GL; Miwa, GT | 1 |
| Aldunate, J; Letelier, ME; Morello, A; Repetto, Y | 1 |
| Beaulieu, BB; Chrystal, EJ; Goldman, P; Koch, RL; McLafferty, MA; Sudlow, G; Yeung, TC | 1 |
| Gallerano, RH; Meirovich, CI; Montrull, HL; Sosa, RR | 1 |
| Liu, SF; Raleigh, JA | 1 |
| Derache, P; Derache, R; Massol, M | 1 |
| Lu, AY; West, SB; Wislocki, PG; Wolf, FJ | 1 |
| Clarke, ED; Goulding, KH; Wardman, P | 2 |
| Josephy, PD; Palcic, B; Skarsgard, LD | 1 |
| White, RA; Workman, P | 1 |
| Chan, YW; Cyr, JE; Linder, KE; Malley, MF; Nowotnik, DP; Nunn, AD | 1 |
| Gallerano, RR; Sosa, RR | 1 |
| Colmenarez-Mendoza, HJ; Dávila-Spinetti, DF; Lobo-Vielma, L | 1 |
| A, IZ; B, WA; G, IH; H, IN; H, MT; L, MI; M, LJ; P, JS; V, AM; V, PM | 1 |
| Bartel, LC; Castro, JA; Montalto de Mecca, M | 1 |
| Bestetti, RB; Theodoropoulos, TA | 1 |
| Bartel, LC; Bietto, FM; Castro, JA; de Castro, CR; Montalto de Mecca, M | 1 |
| Bua, J; Bustos, PL; Fichera, LE; Gonzalez, MN; Grosso, NL; Perrone, AE; Postan, M | 1 |
| Albareda, MC; Alvarez, MG; Armenti, AH; Bertocchi, G; Cooley, G; Laucella, SA; Lococo, BE; Perez-Mazliah, DE; Petti, M; Tarleton, RL; Viotti, R | 1 |
| Alarcon, ML; Bua, J; Fichera, LE; Grosso, NL; Laucella, SA; Riarte, A | 1 |
| Benatar, AF; Búa, J; Esteva, MI; Fichera, LE; López Alarcón, M; Prado, NG; Rial, MS; Riarte, AR; Scalise, ML | 1 |
| Assíria, T; Bahia, MT; Diniz, LF; Gonçalves, KR; Mazzeti, AL; Ribeiro, I; WonDollinger, RS | 1 |
| Cardoso Santos, E; Dias Novaes, R; Lima, GDA; Oliveira Silva, R; Santana Nogueira, S; Vilela Gonçalves, R | 1 |
3 review(s) available for azomycin and allopurinol
| Article | Year |
|---|---|
[Biochemical bases of the action of anti-chagasic drugs].
Topics: Allopurinol; Animals; Free Radicals; Gentian Violet; Glutathione; Humans; Nifurtimox; Nitroimidazoles; Oxidation-Reduction; Trypanocidal Agents; Trypanosoma cruzi | 1988 |
A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease.
Topics: Allopurinol; Chagas Disease; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Neoplasms; Nitroimidazoles; Perioperative Care; Postoperative Complications; Recurrence; Trypanocidal Agents | 2009 |
Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials.
Topics: Allopurinol; Chagas Disease; Drug Therapy, Combination; Humans; Nitroimidazoles; Randomized Controlled Trials as Topic; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
3 trial(s) available for azomycin and allopurinol
| Article | Year |
|---|---|
Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
Topics: Adult; Allopurinol; Chagas Disease; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Nifurtimox; Nitroimidazoles; Trypanocidal Agents | 1990 |
[Allopurinol in the treatment of chronic Chagas' disease].
Topics: Allopurinol; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Nifurtimox; Nitroimidazoles; Trypanocidal Agents | 1985 |
Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.
Topics: Adult; Allopurinol; Antiprotozoal Agents; B-Lymphocytes; Chagas Disease; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Pilot Projects; T-Lymphocytes; Treatment Outcome; Trypanosoma cruzi | 2013 |
19 other study(ies) available for azomycin and allopurinol
| Article | Year |
|---|---|
Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite.
Topics: Animals; Chemical Phenomena; Chemistry; Dithionite; Liver; NADPH-Ferrihemoprotein Reductase; Nitroimidazoles; Nitroreductases; Rats; Rats, Inbred Strains; Ronidazole; Sulfites; Xanthine Oxidase | 1988 |
Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity.
Topics: Animals; Bacteria, Anaerobic; Biotransformation; Cecum; DNA Repair; Enterobacteriaceae; Germ-Free Life; Humans; Metronidazole; Mutation; Nitroimidazoles; Oxidation-Reduction; Structure-Activity Relationship; Xanthine Oxidase | 1986 |
Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases--glyoxal formation from misonidazole.
Topics: Acetylcholinesterase; Animals; Cell Line; Cricetinae; Cricetulus; Female; Glyoxylates; L-Lactate Dehydrogenase; Misonidazole; Nitroimidazoles; Ovary; Xanthine Oxidase | 1983 |
[Effects of nitroimidazole and nitrofuran derivatives on uric acid formation in an anaerobic environment by xanthine oxidase and microsomal nitroreductase].
Topics: Animals; In Vitro Techniques; Microsomes; Nitrofurans; Nitroimidazoles; Nitroreductases; Oxidoreductases; Rats; Rats, Inbred Strains; Uric Acid; Xanthine Oxidase | 1983 |
Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro.
Topics: Alkylation; Anaerobiosis; Animals; Flavin Mononucleotide; Male; Methylcholanthrene; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Nitroimidazoles; Protein Binding; Rats; Ronidazole; Serum Albumin, Bovine; Xanthine Oxidase | 1982 |
Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase.
Topics: Anaerobiosis; Electron Transport; Flavin Mononucleotide; Kinetics; Nitroimidazoles; Nitroso Compounds; Oxidation-Reduction; Xanthine Oxidase | 1980 |
Reduction of misonidazole and its derivatives by xanthine oxidase.
Topics: Hypoxia; In Vitro Techniques; Misonidazole; Nitroimidazoles; Oxidation-Reduction; Xanthine Oxidase | 1981 |
Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
Topics: Allopurinol; Animals; Kidney; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Xanthine Oxidase | 1982 |
Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.
Topics: Anaerobiosis; Chemical Phenomena; Chemistry, Physical; Electron Transport; Nitroimidazoles; Oxidation-Reduction; Time Factors; Xanthine Oxidase | 1982 |
TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Topics: Chromatography, High Pressure Liquid; Crystallization; Crystallography, X-Ray; Dimethylformamide; Electrochemistry; Hypoxia; Kinetics; Magnetic Resonance Spectroscopy; Molecular Structure; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Stereoisomerism; Xanthine Oxidase | 1994 |
[Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
Topics: Adolescent; Adult; Aged; Allopurinol; Antiprotozoal Agents; Chagas Cardiomyopathy; Chagas Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nifurtimox; Nitroimidazoles; Prospective Studies; Retrospective Studies; Time Factors; Treatment Outcome; Trypanocidal Agents | 2000 |
[Mechanisms responsible for myocardial damage progression in chronic Chagas' disease].
Topics: Allopurinol; Antimetabolites; Chagas Cardiomyopathy; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Electrocardiography; Follow-Up Studies; Humans; Nitroimidazoles; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Trypanocidal Agents | 2005 |
[Part VI. Antiparasitic treatment for Chagas disease].
Topics: Allopurinol; Animals; Chagas Disease; Follow-Up Studies; Humans; Immunocompromised Host; Immunosuppressive Agents; Nifurtimox; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Nitroreductive metabolic activation of some carcinogenic nitro heterocyclic food contaminants in rat mammary tissue cellular fractions.
Topics: Allopurinol; Animals; Carcinogens; Female; Food Contamination; Hypoxanthine; Mammary Glands, Animal; Molecular Structure; NADP; Nitrofurans; Nitroimidazoles; Nitroreductases; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2009 |
Metabolization of nifurtimox and benznidazole in cellular fractions of rat mammary tissue.
Topics: Allopurinol; Animals; Cell Fractionation; Chromatography, High Pressure Liquid; Female; Lipid Peroxidation; Mammary Glands, Animal; Microscopy, Electron, Transmission; Microsomes; Nifurtimox; Nitroimidazoles; Nitroreductases; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Trypanocidal Agents | 2010 |
Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.
Topics: Allopurinol; Animals; Cell Line; Cells, Cultured; Chagas Disease; Endemic Diseases; Inhibitory Concentration 50; Insect Vectors; Mice; Mice, Inbred C3H; Muscle Cells; Muscles; Nicaragua; Nitroimidazoles; Phylogeny; Rats; Triatoma; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Combined treatment with benznidazole and allopurinol in mice infected with a virulent Trypanosoma cruzi isolate from Nicaragua.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Chagas Disease; Disease Models, Animal; Drug Therapy, Combination; Mice; Nicaragua; Nitroimidazoles; Survival Analysis; Treatment Outcome; Trypanosoma cruzi | 2013 |
Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.
Topics: Allopurinol; Animals; Chagas Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Nitroimidazoles; Random Allocation; Specific Pathogen-Free Organisms; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi.
Topics: Allopurinol; Animals; Cell Line; Chagas Disease; Humans; Mice; Mortality; Nifurtimox; Nitroimidazoles; Real-Time Polymerase Chain Reaction; Trypanosoma cruzi | 2019 |